Report #2856486

Received Sep 2, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 64 yrs
State: SC
Recovered: Unknown
Vaccinated: Aug 23, 2025
Onset: Aug 23, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	7523J	—

Symptoms (1)

Incorrect dose administered

Symptom narrative

Incorrect vaccine schedule; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 7523J) for prophylaxis. Concomitant products included Varicella zoster vaccine rgE (CHO) (Shingrix). On 23-AUG-2025, the patient received the 2nd dose of Shingrix. On 23-AUG-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: Incorrect vaccine schedule). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK Receipt Date: 25-AUG-2025 The reporter reported that a patient here that got the Shingrix vaccine on 09th August 2025, and then they just got a notification he got a 2nd one in 23rd August 2025 which led to shortening of vaccination schedule. The vaccine administration facility was the same as primary reporter.